Linear IgA bullous dermatosis: Comparison between the drug-induced and spontaneous forms

British Journal of Dermatology

Volumn 169, Issue 5, 2013, Pages 1041-1048

  Chanal, J ^a   Ingen Housz Oro, S ^a   Ortonne, N ^a   Duong, T A ^a,b   Thomas, M ^a,b   Valeyrie Allanore, L ^a   Lebrun Vignes, B ^c   Andre C ^a,b   Roujeau, J C ^a,b   Chosidow, O ^a,b,d   Wolkenstein, P ^a,b,d  

^a HENRI MONDOR HOSPITAL   (France)

^b UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; DAPSONE; IMIPENEM; KETOPROFEN; VANCOMYCIN; VERAPAMIL; VIGABATRIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG INDUCED LINEAR IGA BULLOUS DERMATOSIS; DRUG SAFETY; ERYTHEMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LINEAR IGA BULLOUS DERMATOSIS; MALE; MODIFIED BEGAUD SCORE; NARANJO SCORE; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SCORING SYSTEM; SKIN BIOPSY; SKIN MANIFESTATION; SPONTANEOUS LINEAR IGA BULLOUS DERMATOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; DRUG ERUPTIONS; FEMALE; HUMANS; LINEAR IGA BULLOUS DERMATOSIS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84887037856     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12488     Document Type: Article

References (34)

1. Prystowsky S, Gilliam JN,. Benign chronic bullous dermatosis of childhood. Linear IgA and C3 deposition on the basement membrane. Arch Dermatol 1976; 112: 837-8.
2. Paul C, Wolkenstein P, Prost C, et al,. Drug-induced linear IgA disease: target antigens are heterogeneous. Br J Dermatol 1997; 136: 406-11.
3. Sobjanek M, Sokolowska-Wojdylo M, Sztaba-Kania M, et al,. Clinical and immunopathological heterogeneity of 22 cases of linear IgA bullous dermatosis. J Eur Acad Dermatol Venereol 2008; 22: 1131.
4. Horiguchi Y, Ikoma A, Sakai R, et al,. Linear IgA dermatosis: report of an infantile case and analysis of 213 cases in Japan. J Dermatol 2008; 35: 737-43.
5. Waldman MA, Black DR, Callen JP,. Vancomycin-induced linear IgA bullous disease presenting as toxic epidermal necrolysis. Clin Exp Dermatol 2004; 29: 633-6.
6. Dellavalle RP, Burch JM, Tayal S, et al,. Vancomycin-associated linear IgA bullous dermatosis mimicking toxic epidermal necrolysis. J Am Acad Dermatol 2003; 48: S56-7.
7. Gabrielsen TO, Staerfelt F, Thune PO,. Drug-induced bullous dermatosis with linear IgA deposits along the basement membrane. Acta Derm Venereol 1981; 61: 439-41.
8. Whitworth JM, Thomas I, Peltz SA, et al,. Vancomycin-induced linear IgA bullous dermatosis (LABD). J Am Acad Dermatol 1996; 34: 890-1.
9. Baden LA, Apovian C, Imber MJ, Dover JS,. Vancomycin-induced linear IgA bullous dermatosis. Arch Dermatol 1988; 124: 1186-8.
10. Primka EJ 3rd, Liranzo MO, Bergfeld WF, Dijkstra JW,. Amiodarone-induced linear IgA disease. J Am Acad Dermatol 1994; 31: 809-11.
11. Plunkett RW, Chiarello SE, Beutner EH,. Linear IgA bullous dermatosis in one of two piroxicam-induced eruptions: a distinct direct immunofluorescence trend revealed by the literature. J Am Acad Dermatol 2001; 45: 691-6.
12. Bouldin MB, Clowers-Webb HE, Davis JL, et al,. Naproxen-associated linear IgA bullous dermatosis: case report and review. Mayo Clin Proc 2000; 75: 967-70.
13. Avci O, Okmen M, Cetiner S,. Acetaminophen-induced linear IgA bullous dermatosis. J Am Acad Dermatol 2003; 48: 299-301.
14. Yawalkar N, Reimers A, Hari Y, et al,. Drug-induced linear IgA bullous dermatosis associated with ceftriaxone- and metronidazole-specific T cells. Dermatology 1999; 199: 25-30.
15. Combemale P, Gavaud C, Cozzani E, et al,. Linear IgA dermatosis induced by penicillin G. Ann Dermatol Venereol 1993; 120: 847-8.
16. Fortuna G, Salas-Alanis JC, Guidetti E, Marinkovich MP,. A critical reappraisal of the current data on drug-induced linear immunoglobulin A bullous dermatosis: a real and separate nosological entity? J Am Acad Dermatol 2012; 66: 988-94.
17. Ingen-Housz-Oro S, Bernard P, Bedane C, et al,. Linear IgA dermatosis. Guidelines for the diagnosis and treatment. Centres de référence des maladies bulleuses auto-immunes. Société Française de Dermatologie. Ann Dermatol Venereol 2011; 138: 267-70.
18. Bégaud B, Evreux JC, Jouglard J, Lagier G,. Imputation of the unexpected or toxic effects of drugs. Actualization of the method used in France. Therapie 1985; 40: 111-18.
19. Arimone Y, Bidault I, Dutertre J-P, et al,. Update of the French drug reaction assessment method. Therapie 2011; 66: 517-25.
20. Naranjo CA, Busto U, Sellers EM, et al,. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-45.
21. Benahmed S, Picot M-C, Dumas F, Demoly P,. Accuracy of a pharmacovigilance algorithm in diagnosing drug hypersensitivity reactions. Arch Intern Med 2005; 165: 1500-5.
22. Schroeder D, Saada D, Rafaa M, et al,. Verapamil-induced linear IgA disease mimicking toxic epidermal necrolysis. Ann Dermatol Venereol 2011; 138: 302-6.
23. Wojnarowska F, Marsden RA, Bhogal B, Black MM,. Chronic bullous disease of childhood, childhood cicatricial pemphigoid, and linear IgA disease of adults. A comparative study demonstrating clinical and immunopathologic overlap. J Am Acad Dermatol 1988; 19: 792-805.
24. Jawitz RS, Krach K, Schapiro B,. A vesiculobullous eruption in a hospitalized patient. Diagnosis: drug-induced linear IgA bullous dermatosis (LAD) with eosinophils. Arch Dermatol 2011; 147: 1443-8.
25. Friedman IS, Rudikoff D, Phelps RG, Sapadin AN,. Captopril-triggered linear IgA bullous dermatosis. Int J Dermatol 1998; 37: 608-12.
26. Nantel-Battista M, Al Dhaybi R, Hatami A, et al,. Childhood linear IgA bullous disease induced by trimethoprim-sulfamethoxazole. J Dermatol Case Rep 2010; 4: 33-5.
27. Acostamadiedo JM, Perniciaro C, Rogers RS 3rd,. Phenytoin-induced linear IgA bullous disease. J Am Acad Dermatol 1998; 38: 352-6.
28. Ho JCC, Ng PL, Tan SH, Giam YC,. Childhood linear IgA bullous disease triggered by amoxicillin-clavulanic acid. Pediatr Dermatol 2007; 24: E40-3.
29. König C, Eickert A, Scharfetter-Kochanek K, et al,. Linear IgA bullous dermatosis induced by atorvastatin. J Am Acad Dermatol 2001; 44: 689-92.
30. McWhirter JD, Hashimoto K, Fayne S, Ito K,. Linear IgA bullous dermatosis related to lithium carbonate. Arch Dermatol 1987; 123: 1120-2.
31. Del Pozo J, Martínez W, Yebra-Pimentel MT, et al,. Linear immunoglobulin A bullous dermatosis induced by gemcitabine. Ann Pharmacother 2001; 35: 891-3.
32. Shimanovich I, Rose C, Sitaru C, et al,. Localized linear IgA disease induced by ampicillin/sulbactam. J Am Acad Dermatol 2004; 51: 95-8.
33. Cerottini JP, Ricci C, Guggisberg D, Panizzon RG,. Drug-induced linear IgA bullous dermatosis probably induced by furosemide. J Am Acad Dermatol 1999; 41: 103-5.
34. Guillaume JC, Escudier B, Espagne E, et al,. Bullous dermatosis with linear IgA deposits along the basement membrane during treatment with gamma interferon and interleukin-2. Ann Dermatol Venereol 1990; 117: 899-902.